The WHO recommendations really encourage the adoption of such technologies, furnished they are often validated to show equivalent or excellent performance when compared to standard methods. Manufacturers seeking to carry out these solutions must deliver robust validation information to demonstrate their equivalence to pharmacopoeial solution